Desmethylflunitrazepam

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Headbomb (talk | contribs) at 14:31, 28 June 2016 (→‎top: clean up using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Desmethylflunitrazepam
Legal status
Legal status
Identifiers
  • 5-(2-fluorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.018.072 Edit this at Wikidata
Chemical and physical data
FormulaC15H10FN3O3
Molar mass299.261 g·mol−1
3D model (JSmol)
  • FC1=C(C=CC=C1)C2=NCC(NC3=C2C=C(C=C3)[N+](=O)[O-])=O
  • InChI=1S/C15H10FN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)
  • Key:KNGIGRDYBQPXKQ-UHFFFAOYSA-N

Desmethylflunitrazepam (Ro05-4435, fonazepam) is a benzodiazepine that is a metabolite of flunitrazepam.[1][2][3] It has an IC50 value of 1.499 nM for the GABAA receptor.[4][5]

See also

References

  1. ^ Ruud W. Busker; Gerard M.J.Beijersbergen van Henegouwen; Brigitta M.C. Kwee; Jos H.M. Winkens (May 1987). "Photobinding of flunitrazepam and its major photo-decomposition product N-desmethylflunitrazepam". International Journal of Pharmaceutics. 36 (2–3): 113–120. doi:10.1016/0378-5173(87)90145-1.
  2. ^ Janet K Coller; Andrew A Somogyi; Felix Bochner (November 1998). "Quantification of flunitrazepam's oxidative metabolites, 3-hydroxyflunitrazepam and desmethylflunitrazepam, in hepatic microsomal incubations by high-performance liquid chromatography". Journal of Chromatography B. 719 (1–2): 87–92. doi:10.1016/S0378-4347(98)00383-1. PMID 9869368.
  3. ^ Tansel Kilicarslan; Robert L. Haining; Allan E. Rettie; Usanda Busto; Rachel F. Tyndale; Edward M. Sellers (April 2001). "Flunitrazepam Metabolism by Cytochrome P450s 2C19 and 3A4". Drug Metabolism and Disposition. 29 (4): 460–465. PMID 11259331.
  4. ^ Desmond J. Maddalena; Graham A. R. Johnston (February 1995). "Prediction of Receptor Properties and Binding Affinity of Ligands to Benzodiazepine/GABAA Receptors Using Artificial Neural Networks". Journal of Medicinal Chemistry. 38 (4): 715–724. doi:10.1021/jm00004a017. PMID 7861419.
  5. ^ Sung-Sau So; Martin Karplus (December 1996). "Genetic Neural Networks for Quantitative Structure−Activity Relationships:  Improvements and Application of Benzodiazepine Affinity for Benzodiazepine/GABAA Receptors". Journal of Medicinal Chemistry. 39 (26): 5246–5256. doi:10.1021/jm960536o. PMID 8978853.